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Abstract
Primary pulmonary angiosarcoma (PPA) is a rare tumour arising from arterial or venous pulmonary vessels of various size. It is 
characterized by aggressive course and poor prognosis. The early diagnosis is difficult due to diverse clinical and radiological 
manifestations. We present a case report of 70 year-old man, active cigarette-smoker, with a 2-month history of non-massive 
hemoptysis. The thorax CT revealed several solid pulmonary nodules surrounded by areas of ground glass opacity. As bronchosco-
py failed to deliver adequate tissue samples, video assisted thoracic surgery (VATS) with pleura and lung biopsy was necessary. 
Histopathological findings were consistent with pulmonary angiosarcoma. Since no extrapulmonary lesions were demonstrated, 
the final diagnosis of primary pulmonary angiosarcoma was made. The patient died three months after the onset of symptoms. 
Our case report highlights that differential diagnosis in patients with hemoptysis and pulmonary nodules should include primary 
pulmonary sarcoma.
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Case presentation
A 70-year-old man was referred to our depart-
ment from one of municipal hospitals in January 
2016 with a 2-month history of non-massive he-
moptysis (daily volume of expectorated blood was 
approximately 15 ml). The patient also reported 
weight loss of 3 kg during the last month, general 
weakness and mild recurrent epistaxis. His past 
medical history included arterial hypertension 
and chronic sinusitis, both diagnosed approxi-
mately 10 years ago. He had also undergone 
endovascular stent grafting of abdominal aorta 
aneurysm as well as transurethral resection of 
the prostate due to benign prostatic hyperplasia. 
He was an active cigarette-smoker with a history 
of 52 pack-years of tobacco smoking. During the 
hospitalisation in the municipal hospital two 
pulmonary nodules in the left lower lobe were 
found in chest radiograph. These findings were 
confirmed in thorax CT scan which also showed 
ground glass areas surrounding the nodules (halo 
sign). 
On admission the patient’s general condition 
was satisfactory. His vital signs were within normal 
range: arterial blood pressure was 120/80 mm Hg, 
heart rate 80 beats per minute, transcutaneous 
arterial oxygen saturation 93% while breathing 
room air. Dullness to percussion and diminished 
breath sounds over the left lower lung field was 
noted on physical examination. Except these 
findings the physical examination did not reveal 
any relevant abnormalities. 
The results of laboratory studies showed nor-
mocytic anaemia (hemoglobin level 90.5 g/L), an 
elevated peripheral white blood cell count (WBC) 
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Figure 2. The chest CT at four different scan levels demonstrating several nodules in subpleural regions of both lungs and adjacent areas of irreg-
ular ground-glass opacities (halo sign). There is a large area of ground-glass attenuation with thickening of interlobular septa in the left lower lobe 
corresponding to alveolar hemorrhage
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(13.7 × 109/L) and increased serum concentration 
of C-reactive protein (116.8 mg/L). The chest X-ray 
demonstrated extensive parenchymal opacities 
in the left lower lung field. Some different sized, 
ill-defined pulmonary nodules were also seen in 
both peripheral lung fields (Fig. 1). The chest CT 
scan confirmed several nodules in subpleural 
regions of both lungs surrounded by irregular 
ground-glass areas (halo sign). There was a large 
area of ground-glass opacity with thickening of in-
terlobular septa in the left lower lobe and at least 
two nodules located within the area of increased 
attenuation. There were no features of pulmonary 
emboli or mediastinal lymph nodes enlargement 
(Fig. 2). Computed tomography of paranasal si-
nuses demonstrated mild thickening of the sinus 
lining with small polyps in maxillary and ethmoid 
sinuses. An abdominal ultrasound did not show 
any abnormalities. Also, an echocardiography 
and lower limbs venous ultrasonography did not 
reveal any abnormal endovascular findings. The 
endcoscopy of nasal cavity and sinuses did not 
show any significant mucosal lesions or local 
bleeding. 
Since granulomatosis with polyangitis was 
one of the differential diagnoses, the serum 
level of antineutrophil cytoplasmic antibodies 
(ANCA) was assessed. However, serum ANCA, 
as well as anti-nuclear antibodies (ANA) were 
within the normal limits. Fiberoptic bronchos-
copy was performed as the next diagnostic step. 
This revealed fresh blood in the central and pe-
ripheral airways. However, after blood removal 
Figure 1. Posteroanterior chest radiograph taken on admission show-
ing a large parenchymal opacity in the left lower lung field and several 
ill-defined nodules in both peripheral lung fields 
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and bronchial washing there was no evidence of 
endobronchial tumour or other endobronchial 
sources of bleeding. Intensified bloody appear-
ance of the consecutive bronchoalveolar lavage 
(BAL) samples was consistent with alveolar hem-
orrhage. Transbronchial lung biopsy of the left 
lower lobe was also performed and histological 
examination of the biopsy specimen showed non-
specific chronic inflammation with some minor 
interstitial lung fibrosis. No malignant cells were 
found. All microbiological examinations of BALF, 
including bacterial and fungal cultures, Aspergil-
lus galactomannan as well as direct microscopy 
and PCR for Mycobacteria gave negative results.
During 14 days of hospital stay several ep-
isodes of fever (max. 38,5°C) were observed. 
However, the serum concentration of procalci-
tonin was within the normal range and the blood 
cultures were negative. Except increasing volume 
of left sided pleural effusion the chest radiograph 
did not show any new parenchymal opacities. As 
transthoracic ultrasound showed highly echogen-
ic effusion with multiple loculations the patient 
was not regarded a good candidate for diagnostic 
thoracentesis. Due to further decrease in blood 
hemoglobin concentration to 80.1 g/L the patients 
received transfusion of 5 units of red blood cells. 
Since an extensive workup did not reveal 
the nature of pulmonary lesions and a true cause 
of pulmonary bleeding remained unknown, the 
patient was scheduled for video assisted thorac-
ic surgery (VATS) with pleura and lung biopsy. 
During the procedure 800 ml of bloody effusion 
was removed from left pleural cavity. Intra-oper-
ative visual inspection of the left pleural cavity 
revealed markedly thickened and hypervascular-
ized parietal and visceral pleura with some clots 
in the pleural cavity, atelectatic lung and necrotic 
lung specimen. The samples of parietal pleura 
and the lower lobe of the left lung were obtained 
for histopathological analysis. 
Microscopic examination of pleural samples 
showed a big amount of necrotic masses intermin-
gled with clots and necrotizing neoplastic cells. 
Lung samples revealed neoplastic infiltration 
involving visceral pleura and subpleural lung 
parenchyma. The cells were large, epithelioid 
with atypical, polygonal nuclei and conspicuous 
eosinophilic nucleoli. A high number of mitotic 
figures was observed, some figures were atypi-
cal. Neoplastic cells did not form any organoid 
structures. In the lung parenchyma the neoplas-
tic cells infiltrated not only interalveolar septa 
but also filled the lumen of alveoli along with 
erythrocytes, fibrinous exudate and numerous 
hemosiderin-laden macrophages. The immuno-
histochemical analysis of the neoplasm revealed 
weak and focal reactivity with anti-CD31 (JC70, 
Cell Marque, CM) and Factor VIII (polyclonal, 
CM) antibody and strong and diffuse expression 
of vimentin (V9, Ventana Medical Systems Inc, 
VMS), WT-1 (6F-H2, CM) and FLI-1 (MRQ1, CM) 
(Fig. 3). The reactions with anti-pankeratin (AE-
1AE3/PCK26, VMS), EMA (E29, VMC), TTF-1 
(SP141, VMS), p63 (HA4, VMS), CEA (CEA31, 
CM), Ep-CAM (Ber-Ep4, CM), podoplanin (D2-40, 
CM) and S-100 (polyclonal, VMS) were all neg-
ative. Single cells demonstrated weak reactivity 
with anti-calretinin (SP65, VMS), anti-MART1/
Melan A  (A103, VMS) and anti-melanosome 
(HMB-45, VMS) antibodies but these reactions 
were considered as false positive. Histochemi-
cal staining for mucicarmine was also negative. 
The final diagnosis of epithelioid angiosarcoma 
was established. Differential diagnosis included 
epithelioid malignant melanoma, epithelioid 
malignant mesothelioma and non-small cell lung 
carcinoma.
The postoperative period was complicated 
by prolonged drainage of the pleural effusion and 
impaired healing of the chest tube wound. Due 
to decreased blood hemoglobin concentration 
the next transfusion of 4 red blood cell units 
was necessary. Although, the patient’s general 
condition has deteriorated, his hemoptysis was 
categorized as mild and he remained relatively 
stable. Follow-up chest X-ray showed the progres-
sion of parenchymal lesions in the left lung and 
increased volume of pleural effusion in the left 
pleural space (Fig. 4). The results of laboratory 
tests revealed significantly elevated number of 
WBC (30 × 109/L) and serum concentration of 
C-reactive protein (233.9 mg/L). 
On the basis of histopathology findings, a fi-
nal diagnosis of pulmonary angiosarcoma was 
made. As previous imaging studies of abdomen, 
heart and lower limbs veins had not demonstra-
ted any extrapulmonary vascular lesions primary 
pulmonary angiosarcoma (PPA) was diagnosed. 
The patient was discharged and referred to on-
cology centre to consider any further therapeutic 
options. However, five days after leaving our 
department, the patient died at home, probably 
due to the progression of the disease. Post-mortem 
examination has not been performed.
Discussion
Angiosarcoma is an uncommon soft tissue 
tumour that represents about 1−2% of all sarco-
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Figure 3. Epithelioid angiosarcoma of the lung — histopathological examination. A, B — low and high magnification of the neoplastic infiltration com-
posed of huge, highly atypical epithelioid cells mixed with erythrocytes, yellowish haemosiderin-laden macrophages and pink, homogenous masses 
of fibrin (HE staining, magn. × 100 and × 400); C, D — anti-CD31 positive membranous reaction (C) and Factor VIII (D) in a group of neoplastic cells 
(CD31, magn. × 400; FVIII, magn. × 400); E — diffuse nuclear anti-FLI-1 reaction (FLI-1, magn. × 400); F — prominent cytoplasmic anti-WT-1 reaction 
in majority of cells (WT-1, magn. × 400)
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mas. It primarily develops in skin, liver, breast, 
trunk, heart, chest, bones and extremities. The 
known risk factors are exposure to therapeutic 
radiation, chemicals (vinyl chloride, radium, 
anabolic steroids) and chronic lymphoedema 
caused by different conditions [1, 2]. To the best 
of our knowledge the reported patients had no 
history of exposure to known causative factors. 
This is consistent with other reports on primary 
pulmonary angiosarcomas [3−5]. 
In the majority of patients with pulmonary 
angiosarcoma lung involvement represents me-
tastases from primary extrapulmonary sites of 
the diseases. Primary pulmonary angiosarcoma 
(PPA) is a very rare tumour arising from arterial 
or venous pulmonary vessels of various size. 
According to one recent paper only 32 case re-
ports had been published to 2015 [6]. However, 
the above number is certainly to low, as at least 
several reports have not been identified by the 
authors of this paper [7, 8]. The mean age of pa-
tients affected by PPA was 55,9 years (range, 23-82 
years), with significant men predominance [6]. 
The early diagnosis is very difficult due to 
non-specific signs and symptoms presented by 
the patients. The majority of reports emphasize 
the following symptoms: (1) hemoptysis (the most 
common sign related to the vessel injury [7, 9], 
(2) cough, dyspnea (related to local growth) [7], 
(3) chest pain [1], (4) non-specific symptoms: 
weight loss, malaise, fatigue, fever [5, 7, 10]. 
Nevertheless, some patients may present the 
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tration [6, 11, 12]. Pulmonary angiosarcomas are 
often associated with ground-glass opacity (halo 
sign) and mediastinal lymphadenopathy [12]. 
Presence of pleural effusion strongly suggest 
pleural invasion [7]. 
A thorough analysis of the literature reveals 
two major patterns of radiologic presentations of 
PPA: a single tumor or mass and multiple nodules 
of different shape and size [7]. A slight predomi-
nance of solitary tumors has been reported [7]. 
The differential diagnosis of these radiological 
patterns covers numerous pulmonary pathologies 
including lung carcinoma, infectious pneumonia 
(e.g. invasive pulmonary mycoses, tuberculosis), 
interstitial pneumonia associated with autoim-
munological disease (e.g. granulomatosis with 
polyangitis) and metastatic malignancies [7, 13]. 
There have been two reports demonstrating 
that PET/CT scan was a helpful tool in imaging 
pulmonary and pleural lesions which were later 
identified as PPA [11, 14]. 
The role of bronchoscopy in establishing the 
diagnosis is equivocal. In majority of patients 
with PPA different amount of blood in bronchi, 
with or without other nonspecific changes were 
reported. Although direct visualization of the 
airways with bronchoscopy may help to localize 
the source of bleeding, bronchoscopy rarely pro-
vide the adequate tissue samples enabling the 
pathologic diagnosis. This is because specific 
endobronchial lesions are uncommon. In three 
patients a  tumor or mass occluding bronchus 
and slowly growing hemorrhagic tumor were re-
ported [10, 15, 16]. Also, tissue samples obtained 
by transbronchial biopsy are rarely sufficient to 
diagnose the nature of the tumor. Thus, VATS 
or even thoracotomy with lung biopsy is often 
necessary to provide an adequate material for 
histopathological examination [7, 8]. This was 
also the case in our patient. 
Microscopic examination revealed the neo-
plastic infiltration by large, epithelioid cells with 
prominent atypia and concurrent morphological 
evidence of haemorrhage, i.e. a great number of 
haemosiderin-laden macrophages, extravasated 
erythrocytes and fibrinous intraalveolar exudate. 
Such epithelioid neoplasm in the lung always 
requires differentiation with non-small cell car-
cinoma, primary or metastatic and epithelioid 
malignant mesothelioma, but both epithelial 
and mesothelial immunohistochemical markers 
were negative. Immunohistochemical profile 
was ambiguous: weak and focal reaction with 
anti-CD31 and Factor VIII, diffuse reaction with 
WT-1 (cytoplasmic) and FLI-1 (nuclear) and weak 
Figure 4. Post-surgery posteroanterior chest radiograph showing 
significant progression of parenchymal opacities in both lungs and 
increased volume of left-sided pleural effusion
asymptomatic course of the disease [11]. Physical 
examination plays limited role in establishing 
the diagnosis of PPA. In patients with alveolar or 
bronchial filling local (or even diffuse) crackles 
can be found on auscultation. Decreased vocal 
fremitus, dullness to percussion and diminished 
breath sounds may suggest pleural involvement 
with pleural effusion. However, these signs are 
not specific and can be found in all patients with 
pleural effusion, regardless of its causes. Blood 
laboratory tests, including the most common but 
nonspecific finding of decreased hemoglobin con-
centration, are not particularly useful in making 
the diagnosis. In our patient, granulomatosis with 
polyangitis was one of the leading differential 
diagnoses. This could have been supported by 
typical symptoms (hemoptysis, history of chronic 
sinusitis and nose bleeding), but was not con-
firmed by the result of ANCA testing. Also, the 
endoscopy of nasal cavity and paranasal sinuses 
did not revealed the typical lesions. 
Primary pulmonary angiosarcoma may have 
various radiologic manifestations. Although chest 
radiograph is usually the first imaging study that 
shows pulmonary and/or pleural lesions, it is 
often insufficient to demonstrate some details 
that can be useful in differentiating between the 
underlying causes. In thorax CT scan PPA can 
present as a  solitary or multiple lung nodule, 
tumor or mass (with or without a halo sign), 
diffuse consolidation, solitary or interstitial infil-
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immunoreactivity with Melan A and HMB-45 in 
single cells. Due to immunohistochemical findin-
gs, two main neoplasms were taken into conside-
ration: epithelioid angiosarcoma and melanoma 
[17−20]. Considering accompanying prominent 
intraalveolar haemorrhage and clinical symptoms 
such as haemoptysis, final diagnosis of epithelioid 
angiosarcoma was established.
There are no strong recommendations on the 
most effective treatment of PPA [10]. Currently, 
the surgical resection of PPA lesions seems to be 
the first line therapy. However, it might be pro-
posed only for patients with early stages of the 
disease presenting with solitary nodule or tumor 
[21]. Due to multifocal lesions and/or poor clinical 
status the majority of patients are not good candi-
dates for surgery. The literature brings evidence 
of using some chemotherapeutic regimens [11, 
13, 22, 23], radiotherapy [5, 16], immunotherapy 
[16], or combination of methods [5, 16, 17, 19]. 
The chemotherapy regimens include gemcitabine, 
docetaxel [23], ifosfamide and adriamycin [12]. 
Stacher et al. suggested that taxanes and trofos-
famide may be particularly beneficial in epithe-
lioid angiosarcoma [24]. Due to the presence of 
the vascular endothelial growth factor (VEGF) 
signalling pathway in angiosarcoma cells, there 
may be a possibility of developing the “targeted 
therapy” [24]. 
The general prognosis in patients with PPA 
is very poor. The data coming from the analysis 
of 24 PPA cases suggests the median survival 
time of 3 months (range 0.5 — 39 months) [7]. 
Similarly, almost one third of patients reviewed 
by Shimabukuro et al. died within the first two 
months after establishing the diagnosis [6]. There 
have been only few reports of survival time longer 
than 12 months [5, 11, 23]. 
Comparing our patient to other patients with 
PPA, we have to admit that the clinical presen-
tation and the course of the disease was very 
similar to those reported in earlier published pa-
pers. Hemoptysis, as the major sign, progressive 
fatigue and disseminated pulmonary nodules 
with halo sign demonstrated in thorax CT scan 
resembled some cases presented by other authors. 
As imaging studies have not demonstrated any 
extrapulmonary foci of the tumor, we believe 
our patient had multifocal primary pulmonary 
angiosarcoma. The course of the disease was quite 
aggressive and the patient died three months after 
the appearance of first symptoms.
In summary, the PPA is a  rare tumour but 
probably not as uncommon as reported previo-
usly. In our single centre experience we had two 
patients with PPA treated in the last 10 years. 
Primary pulmonary angiosarcoma should be con-
sidered as a differential diagnosis in patients with 
hemoptysis and single or multiple lung nodules/
tumors with surrounding ground glass opacity. 
The course of the disease is aggressive, with poor 
prognosis. The only curative treatment seems sur-
gical resection, but the majority of patients with 
PPA are not suitable candidates for major surgery. 
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